New article: Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial. https://t.co/MJg7Dg3ibe
33 followers
580 followers
Phase II of VRC01 broadly neutralising antibodies was not able to show significant therapeutic outcome, published in Lancet HIV https://t.co/c5HNfFYZ4i. Combination treatment being evaluated in two clinical studies: https://t.co/7beF2UKPPj
1,154 followers
RT @TheLancetInfDis: New @TheLancetHIV: Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV…
1,260 followers
RT @TheLancetInfDis: New @TheLancetHIV: Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV…